These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Interferon for prevention of cytomegalovirus reactivation in renal-transplant recipients. Himmelstein DU; Woolhandler S N Engl J Med; 1983 Nov; 309(19):1193. PubMed ID: 6194436 [No Abstract] [Full Text] [Related]
26. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354 [TBL] [Abstract][Full Text] [Related]
27. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients. Pollard RB; Merigan TC Transplant Proc; 1978 Mar; 10(1):241-5. PubMed ID: 205021 [No Abstract] [Full Text] [Related]
28. Acyclovir to prevent cytomegalovirus infection after renal transplantation. Wong T; Toupance O; Chanard J Ann Intern Med; 1991 Jul; 115(1):68. PubMed ID: 1646586 [No Abstract] [Full Text] [Related]
30. Prophylaxis of cytomegalovirus infection in renal transplantation. Kuypers DR; Vanrenterghem Y Nephrol Dial Transplant; 1998 Dec; 13(12):3012-6. PubMed ID: 9870456 [No Abstract] [Full Text] [Related]
31. Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir. Zhang P; Wang W; Zhang L; Li SF; Guan LB; Dong LQ; Zhou S; Yu P Acta Virol; 2013; 57(3):375-7. PubMed ID: 24020766 [No Abstract] [Full Text] [Related]
32. Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients? Khawand N; Light JA; Brems W; Aquino A; Ali A Transplant Proc; 1989 Feb; 21(1 Pt 2):2072-4. PubMed ID: 2540555 [No Abstract] [Full Text] [Related]
33. Early diagnosis of cytomegalovirus infection in renal transplantation. Feletti C; Musiani M; Bonomini V Proc Eur Dial Transplant Assoc; 1980; 17():473-7. PubMed ID: 6264422 [No Abstract] [Full Text] [Related]
34. The morphological consequences and the significance of cytomegalovirus infection in renal transplant patients. Millard PR; Herbertson BM; Nagington J; Evans DB Q J Med; 1973 Jul; 42(167):585-96. PubMed ID: 4353832 [No Abstract] [Full Text] [Related]
36. Vaccination against human cytomegalovirus with live virus. Plotkin SA; Friedman HM; Starr S; Fleisher G Dev Biol Stand; 1982; 52():373-9. PubMed ID: 6299846 [No Abstract] [Full Text] [Related]
37. Acyclovir to prevent cytomegalovirus infection in renal-graft recipients. Grundy JE; Griffiths PD N Engl J Med; 1989 Nov; 321(18):1268-9. PubMed ID: 2552315 [No Abstract] [Full Text] [Related]
38. [Modification of the incidence and course of CMV infections following kidney transplantation by passive immunization--initial experiences with a hyperimmunoglobulin]. Hoyer J; Dennin RH; Schulz E Immun Infekt; 1985 Nov; 13(6):285-9. PubMed ID: 3000921 [TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus infections in human renal transplants. Bone D; Wyllie R; Anderson N; Williams GM Surg Forum; 1973; 24():323-5. PubMed ID: 4377033 [No Abstract] [Full Text] [Related]